September 1, 2017

UMB's New Ventures Initiative (NVI) was launched this spring to quickly turn existing University technologies into companies ready for acquisition or funding. NVI just celebrated its first success with Living Pharma, a UMB startup sold just 18 months after its founding. Living Pharma's technology teaches the body to fight cancer by boosting T cell production.